Marsh & McLennan Companies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRSH research report →
Range $182 – $234
Price Chart
About the company
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals.
- CEO
- John Q. Doyle
- IPO
- 1987
- Employees
- 95,000
- HQ
- New York City, NY, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a constructive long-term uptrend, trading above its 200-day moving average and not far from its 52-week high. That keeps the regime bullish, though the move has matured after a strong multi-month run rather than a deep reset.
Street sentiment is still mixed, but the bias has improved with a fresh upgrade to Overweight and a cluster of higher targets in October and November. The consensus rating sits at Hold, while the average target of about $209.80 is only slightly above the current share price, suggesting fair-value positioning rather than a big rerating.
The earnings profile is clean: Marsh has beaten EPS in all 8 of the last 8 quarters, with the latest surprise at 3.6%. Next-year EPS is modeled at 11.4649 versus 8.36 TTM, so shareholders should watch whether margin discipline and top-line growth keep that upgrade path intact.
Recent insider activity leans negative on discretion, but most of the volume is routine equity awards and exempt transactions. The only clear open-market signal is a 480-share sale by a director, while the larger officer activity appears tied to exempt or automatic flows rather than conviction buying.
Profitability is strong and consistent, with a 24.5% operating margin, 14.2% net margin, and 27.24% ROE. Growth is still healthy too, with revenue up 8.1% year over year and earnings up 11.9%, supported by $5.58 billion in free cash flow in 2025.
Marsh wins on scale, recurring advisory demand, and premium profitability versus most financial-services peers. The stock trades around 20.9x earnings, a valuation that looks reasonable for a high-quality insurance broker with a 5.74% FCF yield and steady execution.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $98.41B
- P/E
- 24.56
- Fwd P/E
- 19.66
- PEG
- -1106146335175492.38
- P/S
- 3.46
- P/B
- 6.68
- EV/EBITDA
- 19.77
- Div Yield
- 1.83%
- Gross Margin
- 42.77%
- Op Margin
- 21.39%
- Net Margin
- 14.20%
- ROE
- 27.15%
- ROIC
- 11.78%
Latest fiscal year · YoY change
- Revenue
- $26.98B+10.3%
- Gross Profit
- $11.40B+9.0%
- Op Income
- $6.22B
- Net Income
- $4.16B+2.5%
- EPS
- $8.48+2.8%
- OCF Growth
- +23.0%
- FCF Growth
- +25.5%
- 52W High
- $214.00
- 52W Low
- $156.60
- 50D MA
- $187.58
- 200D MA
- $178.77
- Beta
- 0.58
- RSI (14)
- 64
- Avg Volume
- 2.48M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Mark posted a strong third quarter with 8% revenue growth, 10% adjusted EPS growth, and higher margin expectations for the year, while raising Thrive savings to $600 million and highlighting AI-led productivity and growth opportunities.· October 15, 2026
- Consolidated revenue rose 8% to $6.9 billion, with underlying growth of 5%; adjusted EPS increased 10% year over year to $2.03.
- Adjusted operating income grew 6% and adjusted operating margin was 22.7% in the quarter; management still expects another year of margin expansion in 2026.
- Thrive savings target was increased from $400 million to $600 million, with savings funding more investment in sales, technology, brand, and new capabilities.
- Consulting was a standout, with management consulting up 14% and strong AI-related demand, while risk growth stayed solid and reinsurance remained pressured by soft pricing.
- Capital returns stayed active: the company repurchased $500 million of stock in the quarter and $2 billion year to date, and still plans about $5.5 billion of capital deployment in 2026.
Consolidated revenue increased 8% to $6.9 billion, or 5% underlying. Adjusted operating income grew 6%, adjusted operating margin was 22.7%, GAAP EPS was $1.69, and adjusted EPS was $2.03, up 10% year over year. For the first 9 months, underlying revenue growth was 5%, adjusted operating income grew 7% to $6.1 billion, adjusted operating margin was 28.1%, and adjusted EPS increased 9% to $8.29. Segmentally, RIS revenue was $4.2 billion, up 7% reported and 3% underlying; reinsurance revenue was $374 million, down 6%; consulting revenue was $2.7 billion, up 9% reported and 8% underlying; and people and investments revenue was $1.7 billion, up 6% reported and 5% underlying. For 2026, management expects underlying revenue growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth. They also expect Q4 fiduciary interest income of about $94 million, Q4 adjusted corporate expense of about $80 million, Q4 interest expense of about $255 million, and an adjusted effective tax rate of around 25% for 2026.
John Quinlan Doyle framed the quarter around structural change in the economy, arguing that clients need more resilience, better insights, and faster adaptation. He emphasized that AI is already affecting the business, not just the future, and said the firm is deploying it responsibly while helping clients manage cyber and other risks. He was upbeat on the company’s positioning, citing trusted client relationships, proprietary datasets, a stronger brand, and the expanded Thrive program as drivers of both growth and efficiency.
Mark Christopher McGivney said the quarter delivered strong top-line and earnings performance, with revenue of $6.9 billion, adjusted operating income of $1.5 billion, adjusted operating margin of 22.7%, and adjusted EPS of $2.03. He noted 9M adjusted operating income of $6.1 billion and said the company still expects another year of margin expansion, while balancing that with investment for growth. On capital allocation, he highlighted $1.3 billion of cash uses in the quarter, including $476 million for dividends, $288 million for acquisitions, and $500 million for buybacks; cash was $1.8 billion and total debt was $20.5 billion. He also said Thrive savings are now expected to reach $600 million, with roughly $750 million of implementation costs, and reiterated the 2026 capital deployment plan of about $5.5 billion.
Analysts pressed management on whether AI could be used more aggressively to expand margins, and John said AI, BCS, right-shoring, and automation are all levers, but he would not talk about a specific margin target like 27% on this call. They also asked about whether a large M&A response to competitors was needed; John said the strategy remains disciplined and balanced, with a preference for a string-of-pearls approach rather than a transformative deal. On consulting, management said AI work is driving demand and sometimes pulling forward success fees, but growth is broader than AI alone and clients are paying for outcomes. Questions on reinsurance softness and EMEA strength were answered with explanations around pricing pressure, mix, market consolidation, and strong regional specialty growth.
The call showed broad-based momentum in consulting, risk, and capital-light productivity initiatives, with management still seeing room for growth despite softer pricing in parts of the market. AI appears to be helping both client demand and internal efficiency, and Thrive’s savings target was raised to $600 million, suggesting more capacity to reinvest while still expanding margins.
Reinsurance remains under pressure from soft pricing and competitive capacity, and management expects those conditions to persist through the January 1 renewal cycle. The company also flagged macro and geopolitical uncertainty, and several analysts raised the risk that AI-driven efficiency could alter pricing, hiring needs, or future growth patterns. In addition, management said there is a bid-ask gap in parts of the M&A market, which could slow deal-making.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.5%
- Shares Outstanding
- 477.21M
- Float Shares
- 475.06M
of shares held by institutions
1,533 13F filers
Buy/sell ratio 1.67. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for MRSH, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Kevin HernHouse · OK01 | Sell | Sep 17, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Sep 23, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Sep 2, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Sep 14, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Sep 9, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Aug 24, 26 | Filing → |
| Alan ArmstrongSenate | Sell | Mar 27, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jun 2, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | May 1, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Apr 13, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Ro KhannaHouse · CA17 | Buy | Jan 13, 26 | Filing → |
| Tina SmithSenate · MN | Sell | Jan 27, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 39.09M | ▼ 410.79K |
| Vanguard Capital Management LLC | 31.24M | ▼ 229.60K |
| State Street Corp | 22.37M | ▼ 30.96K |
| Capital World Investors | 18.66M | ▲ 537.44K |
| Wellington Management Group Llp | 16.98M | ▼ 395.47K |
| Capital International Investors | 15.74M | ▲ 8.56K |
| Price T Rowe Associates Inc | 13.44M | ▲ 2.46M |
| Vanguard Portfolio Management LLC | 12.50M | ▼ 74.72K |
| Geode Capital Management, LLC | 12.07M | ▼ 1.44M |
| Capital Research Global Investors | 10.08M | ▼ 893.17K |
| Harris Associates L P | 8.69M | ▲ 3.52M |
| Fmr LLC | 7.63M | ▲ 677.82K |
Held by 1,754 ETFs
Biggest fund positions in MRSH by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 15, 26 | SCHAPIRO MORTON O | other | 198.01 |
| Nov 13, 26 | SCHAPIRO MORTON O | other | 434.18 |
| Nov 13, 26 | Anderson Anthony | other | 81.8 |
| Nov 16, 26 | Anderson Anthony | sell | 480 |
| Nov 13, 26 | HOPKINS DEBORAH C | other | 102.55 |
| Nov 13, 26 | Ingram Tamara | other | 43.51 |
| Nov 15, 26 | Yates Lloyd M | other | 204.01 |
| Nov 13, 26 | Yates Lloyd M | other | 60.41 |
| Nov 15, 26 | Lute Jane H | other | 130.51 |
| Nov 13, 26 | Lute Jane H | other | 43.36 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MRSH coverage
Recent articles, reports, and earnings notes.

Marsh & McLennan (MRSH): Quality Compounder, But Fairly Priced
Marsh & McLennan combines recurring advisory revenue, strong margins, and steady EPS beats, but debt, reinsurance softness, and valuation keep it at Hold.

Marsh & McLennan Companies, Inc. (MRSH) gains on deep earnings beat
Marsh & McLennan Companies, Inc. (MRSH) gains after a solid third-quarter beat on both EPS and revenue. The deep dive looks beyond the headline, covering consulting strength, risk growth, reinsurance softness, margin expansion, and management’s raised savings plan and 2026 outlook.

Marsh & McLennan Companies, Inc. (MRSH) rises on earnings beats
Marsh & McLennan Companies, Inc. (MRSH) rises 6.4% after reporting earnings beats, as investors react positively to stronger-than-expected quarterly results and improved outlook.
Want a deeper read on MRSH?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Will Synpulse Buyout Boost Marsh's Consulting Growth Prospects?
zacks.com · Nov 20
Marsh to Highlight How Perspective Drives Performance at the Formula 1® Heineken Las Vegas Grand Prix
businesswire.com · Nov 19
Marsh's Oliver Wyman to Acquire Financial Services and Technology Consultancy Synpulse
businesswire.com · Nov 19
Marsh Sees 8.2% Health Cost Surge in 2027: Consulting Growth Ahead?
zacks.com · Nov 18
Marsh's Oliver Wyman Announces Newly Elected Partners and Executive Directors for 2027
businesswire.com · Nov 18
Employers Take Steps to Rein in Health Benefit Cost Growth as Average Cost Reaches $18,777 Per Employee, Marsh Survey Finds
businesswire.com · Nov 17
23,361 Marsh & McLennan Companies, Inc. $MRSH Shares Sold by Allspring Global Investments Holdings LLC
defenseworld.net · Nov 12
Marsh Bets on Wilshire to Expand Wealth and Investment Business
zacks.com · Nov 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 20, 2026 · Live quote · Not investment advice